M&A Deal Summary |
|
|---|---|
| Date | 2022-05-13 |
| Target | GVB Biopharma |
| Sector | Life Science |
| Buyer(s) | 22nd Century Group |
| Deal Type | Add-on Acquisition |
| Advisor(s) | Cowen (Financial) Dorsey & Whitney (Legal) |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1998 |
| Sector | Life Science |
| Employees | 56 |
| Revenue | 12M USD (2024) |
22nd Century Group is a plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing, and modern plant breeding. 22nd Century Group was founded in 1998 and is based in Mocksville, North Carolina.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 3 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 3 |
| State: Nevada M&A | 1 of 1 |
| Country: United States M&A | 1 of 2 |
| Year: 2022 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-01-24 |
RX Pharmatech
Bradford, United Kingdom RX Pharmatech is a distributor of cannabinoids with 1,276 novel food applications with the U.K. Food Standards Agency (FSA). RX Pharmatech is based in Bradford, United Kingdom. |
Buy | - |
